U.S. Softgel Capsules Market Size & Outlook, 2026-2033
Global Market
Related Markets
U.S. softgel capsules market highlights
- The U.S. softgel capsules market generated a revenue of USD 3,018.4 million in 2025 and is expected to reach USD 6,780.5 million by 2033.
- The U.S. market is expected to grow at a CAGR of 10.73% from 2026 to 2033.
- In terms of segment, gelatin-based/animal-based was the largest revenue generating type in 2025.
- Non-Animal-Based is the most lucrative type segment registering the fastest growth during the forecast period.
Softgel capsules market data book summary
| Market revenue in 2025 | USD 3,018.4 million |
| Market revenue in 2033 | USD 6,780.5 million |
| Growth rate | 10.73% (CAGR from 2026 to 2033) |
| Largest segment | Gelatin-based/animal-based |
| Fastest growing segment | Non-Animal-Based |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gelatin-Based/Animal-Based, Non-Animal-Based |
| Key market players worldwide | Thermo Fisher Scientific Inc, EyePoint Pharmaceuticals Inc, Catalent Inc, Kuehne + Nagel International AG, Lonza Group Ltd, Procaps Group SA, Soft Gel Technologies, EuroCaps, Captek Softgel International, Sirio Pharma, Fuji Capsule |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.6% of the global softgel capsules market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. softgel capsules market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 897.5 million by 2033.
The U.S. dominated the overall global softgel market in terms of revenue in 2021, with a market share of 38.72%. According to the 2020 Centers for Medicare and Medicaid Services data, the U.S. spends nearly 19.7% of its GDP on healthcare.
The increasing prevalence of several diseases in the country such as diabetes, cardiovascular diseases, and obesity are some of the key factors expected to boost market growth during the forecast period.
According to the American Heart Association, the data derived from the Nation Health and Nutrition Examination survey suggested that there were an estimated 28.2 Million adults diagnosed with diabetes, 113.6 Million adults had prediabetes, and about 9.8 Million people had undiagnosed diabetes.
No credit card required*
Publish Date: Aug 05, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Softgel Capsules Market Scope
Softgel Capsules Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Kuehne + Nagel International AG | View profile | 93,064 | Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 | www.kuehne-nagel.com |
| Catalent Inc | View profile | 17,219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | www.catalent.com |
| EyePoint Pharmaceuticals Inc | View profile | 144 | 480 Pleasant Street, Suite A-210, Watertown, MA, United States, 02472 | www.eyepointpharma.com |
| Procaps Group SA | View profile | 5,500 | 9 Rue de Bitbourg, Luxembourg, Luxembourg, L-1273 | www.procapsgroup.com |
| Soft Gel Technologies | View profile | 11-50 | Los Angeles, California, United States, North America | www.soft-gel.com/ |
| EuroCaps | View profile | 101-250 | Tredegar, Blaenau Gwent, United Kingdom, Europe | www.eurocaps.co.uk |
| Captek Softgel International | View profile | 251-500 | Cerritos, California, United States, North America | capteksoftgel.com/ |
| Sirio Pharma | View profile | - | Shantou, Guangdong, China, Asia | www.siriopharma.com/ |
U.S. Softgel Capsules Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Softgel Capsules Market Outlook will help companies and investors design strategic landscapes.
Gelatin-Based/Animal-Based was the largest segment with a revenue share of 90.63% in 2025.
Horizon Databook has segmented the U.S. softgel capsules market based on gelatin-based/animal-based, non-animal-based covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. dominated the overall global softgel market in terms of revenue in 2021, with a market share of 38.72%. According to the 2020 Centers for Medicare and Medicaid Services data, the U.S. spends nearly 19.7% of its GDP on healthcare.
The increasing prevalence of several diseases in the country such as diabetes, cardiovascular diseases, and obesity are some of the key factors expected to boost market growth during the forecast period.
According to the American Heart Association, the data derived from the Nation Health and Nutrition Examination survey suggested that there were an estimated 28.2 Million adults diagnosed with diabetes, 113.6 Million adults had prediabetes, and about 9.8 Million people had undiagnosed diabetes.
- U.S. Softgel Capsules Market Type Outlook (Revenue, USD Million , 2021-2033)
- Gelatin-Based/Animal-Based
- Non-Animal-Based
- U.S. Softgel Capsules Market Application Outlook (Revenue, USD Million , 2021-2033)
- Antacid and Anti-Flatulent Preparation
- Anti-Anemic Preparations
- Anti-Inflammatory Drugs
- Antibiotic and Antibacterial Drugs
- Cough and Cold Preparations
- Health Supplement
- Vitamin and Dietary Supplement
- Pregnancy
- U.S. Softgel Capsules Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organization
Reasons to subscribe to Softgel Capsules Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Softgel Capsules Market Outlook databook
- Our clientele includes a mix of Softgel Capsules Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Softgel Capsules Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Softgel Capsules Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Softgel Capsules Market, 2021-2033 (US$M)
U.S. softgel capsules market statistics, by type, 2021-2033 (US$M)
